Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations
- 17 December 2010
- journal article
- Published by Wiley in Histopathology
- Vol. 57 (6), 877-884
- https://doi.org/10.1111/j.1365-2559.2010.03724.x
Abstract
To assess the expression of receptors for androgen (AR), oestrogen (ER) and progesterone (PR) as well as human epidermal growth factor receptor type 2 (Her-2/neu) status of breast carcinomas in breast cancer susceptibility gene (BRCA) BRCA1/2 mutation carriers and BRCA1/2 negative tested women. One hundred and thirty-five breast cancers in women tested for BRCA1/2 mutations. Screening for BRCA1 and BRCA2 mutations was performed by direct sequencing of all BRCA1 and BRCA2 exons as well as the surrounding intronic sequences. Additionally, BRCA genes were analysed with multiplex ligation-dependent probe amplification. Consecutive paraffin sections were examined immunohistochemically for AR, ER, PR and Her-2/neu. Of the 135 tumours, 43 (32%) were BRCA1-related, 18 (13%) were BRCA2-related and 74 (55%) were BRCA1/2-negative. Seventy-two per cent of the BRCA1-related, 22% of the BRCA2-related and 12% of the BRCA1/2-negative tumours were triple (ER, PR, Her2neu)-negative. Eighty-four per cent of BRCA1 mutated cancers were high-grade (G3) tumours. ARs were expressed in 30% (13 of 43) of BRCA1-related, in 78% (14 of 18) in BRCA2-related tumours and in 76% (56 of 74) in BRCA1/2 negative tumours. Twenty-one per cent of ER-negative BRCA1-related tumours expressed androgen receptors. Approximately one in five BRCA1 mutated breast cancers negative for ER and PR express androgen receptors. Modulation of AR might open a new avenue for treating these high-risk cancers.Keywords
This publication has 23 references indexed in Scilit:
- The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identifiedBreast Cancer Research and Treatment, 2007
- BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based studyThe Breast, 2007
- Androgen receptors frequently are expressed in breast carcinomasCancer, 2003
- Breast and Ovarian CancerNew England Journal of Medicine, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- BRCA1 and BRCA2 and the genetics of breast and ovarian cancerHuman Molecular Genetics, 2001
- In search of the tumour-suppressor functions of BRCA1 and BRCA2Nature, 2000
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancerBritish Journal of Cancer, 1996
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994